Weed Advocates Are Ramping Up Lobbying Efforts And Notching Wins

(Photo by Lauren DeCicca/Getty Images)

Daily Caller News Foundation logo
Robert Schmad Contributor
Font Size:

Marijuana legalization advocates are hiring more lobbyists and otherwise ramping up their efforts to influence drug policy on Capitol Hill.

The weed industry’s lobbying efforts increased significantly between the first and second quarters of 2023, rising from $1.04 million to $1.39 million. Cannabis Freedom Alliance, a coalition of groups seeking to end federal prohibitions on weed, recently hired the Bose Public Affairs Group to lobby Congress on marijuana reform issues, according to lobbying disclosures.

Voters in Ohio approved a ballot measure to legalize recreational marijuana on Nov. 7. The Coalition to Regulate Marijuana Like Alcohol, the group behind the ballot measure, spent $5.2 million on efforts to legalize weed in Ohio, according to expenditure records maintained by the Ohio secretary of state.

Cannabis Freedom Alliance includes groups like the Koch-funded Americans for Prosperity, Koch-backed libertarian organizations like the Reason Institute and Students for Liberty as well as pro-marijuana advocacy groups. (RELATED: Biden Admin Recommends Weeding Out Federal Marijuana Restrictions)

Charles Koch, CEO of Koch Industries, has long backed marijuana legalization, spending millions on legalization efforts. Cannabis Freedom Alliance itself launched with the support of Koch, according to the Hill.

Koch initially got the idea to launch Cannabis Freedom Alliance on a Zoom call with Snoop Dogg and another hip-hop artist, Vice reported.

The bump in lobbying activity among marijuana groups coincided with The Secure and Fair Enforcement Regulation Banking Act, a bipartisan bill that would provide legal protection to banks that serve marijuana businesses in states where the substance is legal, being advanced by the Senate Banking Committee.

Twenty-four states and the District of Columbia have legalized cannabis for recreational and medical use, according to the Hill.

Deep-pocketed groups like Bank of America, the National Rifle Association, and Mastercard spent money lobbying on the bill, Forbes reported.

A picture taken on June 5, 2019 shows Marijuana buds, often simply called weed or pot, which is the unprocessed form of the female cannabis plant, at the "Hemp Embassy" store in Milan, one of the first shops in Italy dedicated to cannabis. - Hemp is "legal" marijuana as the THC psychotropic substance is blocked, but can be used for textiles, food, cosmetics and other purposes. (Photo by Miguel MEDINA / AFP) (Photo credit should read MIGUEL MEDINA/AFP/Getty Images)

(Photo by Miguel MEDINA / AFP)

As the lobbyists advocate for loosened restrictions on marijuana usage, some recent research has raised concerns about the substance’s effects on the mental and physical health of users.

Two studies presented at an academic conference earlier this month found that cannabis usage increases the risk of cardiovascular disease, building on other recent studies that found usage of the substance to be associated with the development of schizophrenia and other mental illnesses.

“Prior research shows links between marijuana use and cardiovascular disease like coronary artery disease, heart failure and atrial fibrillation, which is known to cause heart failure,” Dr. Yakubu Bene-Alhasan, the lead researcher on one of the studies presented at the conference, said. “Marijuana use isn’t without its health concerns, and our study provides more data linking its use to cardiovascular conditions.”

Cannabis Freedom Alliance could not be reached for comment.

All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact